In their study of the effect of an LCHF-diet on blood lipids, Burén et al. became worried because, after a few weeks, the participants’ LDL-cholesterol (LDL-C) increased significantly [1]. However, they need not worry. It is correct that many studies have found an association between LDL-C and cardiovascular disease, but association is not the same as causation. In a recent study, we have documented that the cholesterol hypothesis is unable to satisfy any of the Bradford Hill criteria for causality [2]. Accordingly, we have identified 38 studies where the authors have followed more than six million people of all ages for several years after having measured their LDL-C. In three of the studies, mortality was a little higher among those with the highest LDL-C, but mortality was highest among those with the lowest LDL-C. In the other 35 studies, those with the highest LDL-C lived just as long or, in most cases, longer than those with normal or low LDL-C [3,4].
The reason why high LDL-C is beneficial is most likely that LDL participates in our immune system by adhering to and inactivating all types of microorganisms and their toxic products, a little-known fact that has been documented in many ways by more than a dozen research groups [5,6].
Funding
This research received no external funding.
Conflicts of Interest
The authors declare no conflict of interest.
Footnotes
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations.
References
- 1.Burén J., Ericsson M., Damasceno N.R.T., Sjödin A. A Ketogenic Low-Carbohydrate High-Fat Diet Increases LDL Cholesterol in Healthy, Young, Normal-Weight Women: A Randomized Controlled Feeding Trial. Nutrients. 2021;13:814. doi: 10.3390/nu13030814. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 2.Ravnskov U., De Lorgeril M., Diamond D.M., Hama R., Hamazaki T., Hammarskjöld B., Hynes N., Kendrick M., Langsjoen P.H., Mascitelli L., et al. LDL-C does not cause cardiovascular disease: A comprehensive review of the current literature. Expert Rev. Clin. Pharmacol. 2018;11:959–970. doi: 10.1080/17512433.2018.1519391. [DOI] [PubMed] [Google Scholar]
- 3.Ravnskov U., Diamond D.M., Hama R., Hamazaki T., Hammarskjöld B., Hynes N., Kendrick M., Langsjoen P.H., Malhotra A., Mascitelli L., et al. Lack of an association or an inverse association between low-density-lipoprotein cholesterol and mortality in the elderly: A systematic review. BMJ Open. 2016;6:e010401. doi: 10.1136/bmjopen-2015-010401. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4.Ravnskov U., de Lorgeril M., Diamond D.M., Hama R., Hamazaki T., Hammarskjöld B., Harcombe Z., Kendrick M., Langsjoen P.H., McCully K.S., et al. The LDL paradox: Higher LDL-cholesterol is associated with greater longevity. Ann. Epidemiol. Public Health. 2020;3:1040–1047. [Google Scholar]
- 5.Ravnskov U., McCully K.S. Vulnerable plaque formation from obstruction of Vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies. Ann. Clin. Lab. Sci. 2009;39:3–16. [PubMed] [Google Scholar]
- 6.Ravnskov U., McCully K.S. Infections May be Causal in the Pathogenesis of Atherosclerosis. Am. J. Med. Sci. 2012;344:391–394. doi: 10.1097/MAJ.0b013e31824ba6e0. [DOI] [PubMed] [Google Scholar]